ArticleRSC advances2021

Rational design of a potent macrocyclic peptide inhibitor targeting the PD-1/PD-L1 protein-protein interaction.

Qi Miao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.